miR-3614-5p, which has been reported as an antiviral miRNA in dengue virus infection (21), is induced in immune cells by type I IFN and targets adenosine deaminases acting on RNA-1 (ADAR1) to indirectly edit the viral genome (22). This evidence concerns the gene ADAR and dengue disease.